The pandemic caused by the novel coronavirus has shut down countries around the world. STAT held a three-part digital event series that brought together experts to discuss one of society’s biggest hopes – that treatments or even vaccines can be developed. The audience was joined by executives from companies leading the way in developing treatments and they discussed current findings, clinical trials and efforts to expedite approvals as we face this global pandemic.

 

Part 1: Antibody drugs that target the coronavirus

When

Wednesday, April 8, 2020
1:00-2:00PM  

Speakers

• Matt Herper, Senior Writer – Medicine; Editorial Director of Events, STAT 
• Stephen J. Ubl, President and CEO, PhRMA
• George Yancopoulos, Co-Founder, President and Chief Scientific Officer, Regeneron

Watch the video here.

Part 2: Fighting on multiple fronts

When

Wednesday, April 29, 2020
1:00-2:00PM  

Speakers

• Mikael Dolsten, M.D., Ph.D., Chief Scientific Officer, Pfizer
• Matthew Herper, Senior Writer – Medicine; Editorial Director of Events, STAT 
• Richard Moscicki, M.D., Chief Medical Officer, Executive Vice President of Science and Regulatory Advocacy, PhRMA

Watch the video here.

Part 3: Vaccines — can they come soon enough?

When

Wednesday, May 6, 2020
1:00-2:00PM  

Speakers

• Matthew Herper, Senior Writer – Medicine; Editorial Director of Events, STAT 
• Clem Lewin, Ph.D., Associate Vice President of R&D Strategy for Vaccines, Sanofi
• Tal Zaks, Chief Medical Officer, Moderna

Watch the video here.